CV CapsoVision Inc.

Price (delayed)

$7.57

Market cap

$378.22M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.32

Enterprise value

$361.08M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 12

We are a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in our capsule endoscopy solutions to identify abnormalities of the gastrointestinal ...

Highlights
CapsoVision's equity has soared by 115% YoY and by 52% from the previous quarter
CV's quick ratio has soared by 67% YoY and by 30% QoQ
The EPS has dropped by 125% since the previous quarter but it has soared by 77% year-on-year
CV's gross profit is up by 8% year-on-year but it is down by 2.3% since the previous quarter
The net income has contracted by 28% YoY and by 7% from the previous quarter
CV's gross margin is down by 3.9% YoY and by 2.3% QoQ

Key stats

What are the main financial stats of CV

CV stock price

How has the CapsoVision stock price performed over time
Intraday
10.83%
1 week
13.83%
1 month
7.07%
1 year
N/A
YTD
-29.19%
QTD
3.84%

Financial performance

How have CapsoVision's revenue and profit performed over time
Revenue
$13.56M
Gross profit
$7.01M
Operating income
-$27.23M
Net income
-$26.97M
Gross margin
51.7%
Net margin
-198.9%
CV's operating income is down by 29% year-on-year and by 7% since the previous quarter
The net income has contracted by 28% YoY and by 7% from the previous quarter
The company's operating margin fell by 15% YoY and by 7% QoQ
The net margin is down by 14% year-on-year and by 6% since the previous quarter

Price vs fundamentals

How does CV's price correlate with its fundamentals

Growth

What is CapsoVision's growth rate over time

Valuation

What is CapsoVision stock price valuation
P/E
N/A
P/B
18.66
P/S
26.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
26.62
The EPS has dropped by 125% since the previous quarter but it has soared by 77% year-on-year
CapsoVision's equity has soared by 115% YoY and by 52% from the previous quarter
The revenue has grown by 13% YoY

Efficiency

How efficient is CapsoVision business performance
CV's ROIC has plunged by 79% YoY and by 24% from the previous quarter
The ROA has grown by 20% YoY and by 12% from the previous quarter
The ROS is down by 14% year-on-year and by 6% since the previous quarter

Dividends

What is CV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CV.

Financial health

How did CapsoVision financials performed over time
CapsoVision's total assets has surged by 108% YoY and by 43% QoQ
CV's quick ratio has soared by 67% YoY and by 30% QoQ
The debt is 96% smaller than the equity
CapsoVision's equity has soared by 115% YoY and by 52% from the previous quarter
CapsoVision's debt to equity has decreased by 43% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.